Lungcancer Clinical Trial
Official title:
Establishing a Non-invasive Diagnostic Biomarker Test for Early Diagnosis of Lung Cancer
Data on SHOX2 and PTGER4 DNA Methylation suggest possible use as a biomarker for early lung
cancer diagnosis.
In this study a control group consisting of COPD patients with a CT-scan of the chest no
older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of
lung cancer will be included.
SHOX2 and PTGER4 will be analyzed via PCR.
Data on SHOX2 and PTGER4 DNA Methylation suggest possible use as a biomarker for early lung
cancer diagnosis.
In this study a control group consisting of COPD patients with a CT-scan of the chest no
older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of
lung cancer will be included.
A total of 150 patients will be enrolled in this study. SHOX2 and PTGER4 will be analyzed via
PCR of blood plasma samples.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06036563 -
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
|
||
| Completed |
NCT02285426 -
HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study
|
||
| Recruiting |
NCT03020251 -
Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer
|
N/A | |
| Completed |
NCT02962999 -
Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation
|
Phase 4 | |
| Completed |
NCT02185690 -
A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
|
Phase 1 | |
| Recruiting |
NCT02977663 -
Imaging Multiparametric/Multimodality for Lungcancer
|
N/A |